Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
#What Is The Projected Market Size Of The Autoimmune Treatment Market By 2029?
The autoimmune treatment market size has seen rapid expansion in recent years. It is forecast to increase from $7.72 billion in 2024 to $8.63 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 11.7%. This historic growth is attributable to an increasing prevalence, advancements in immunology, insights from genetic research, heightened patient awareness and advocacy, and regulatory support.
The autoimmune treatment market size is projected to expand significantly over the coming years. Its valuation is anticipated to reach $14.54 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 13.9%. This expansion during the forecast period is primarily driven by factors such as precision medicine approaches, the emergence of small molecule therapies, the targeting of novel pathways, innovations in gene therapy, increased biopharmaceutical investments, and the growth of the biosimilar market. Key developments expected within this period encompass advancements in biologics and targeted therapies, the development of immunomodulatory therapies, a sharpened focus on rare autoimmune diseases, the wider adoption of telemedicine and remote monitoring, various regulatory initiatives and drug approvals, and the comprehensive integration of digital health tools.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7863&type=smp
Which Major Market Drivers Are Shaping The Future Of The Autoimmune Treatment Market?
Growing investments in the research and development of drugs for autoimmune diseases are expected to propel the expansion of the autoimmune treatment market. Research and development involves actions taken by businesses to innovate and launch new goods and services. For autoimmune diseases, R&D of drugs enables the creation of more targeted, low-molecular-weight, orally active, and chemically characterized immune suppressive drugs that offer acceptable tolerability for long-term treatment. For instance, in January 2022, Eli Lilly and Company, a US-based pharmaceutical company, increased its R&D investment from $7 billion in 2021 to $7.19 billion in 2022, leading to an increase in its R&D spend as a percentage of revenue from 24.8% to 25.19%. Thus, rising investments in drug research and development are a key driver for the autoimmune treatment market growth.
Which Key Segments Fueling The Autoimmune Treatment Market?
The autoimmune treatmentmarket covered in this report is segmented –
1) By Product: Consumables And Assay Kits; Instruments; Services
2) By Service Type: Consultation And Diagnosis; Therapy And monitoring; Drug development
3) By Disease: Rheumatoid Arthritis; Systemic Lupus Erythematosus; Sjögren’s Syndrome; Thyroiditis; Scleroderma; Other Diseases
4) By Drug Class: Anti-Inflammatory; Anti-Hyperglycemic; NSAIDs; Interferons; Other Drug Class
Subsegments:
1) By Consumables And Assay Kits: ELISA Kits; Reagents And Antibodies; Sample Collection Kits
2) By Instruments: Diagnostic Equipment; Imaging Systems
3) By Services: Testing And Diagnostics Services; Consultation And Support Services; Data Analysis And Interpretation Services
What Are The Major Trends Driving The Growth Of The Autoimmune Treatment Market?
A significant trend gaining traction in the autoimmune treatment market is technological advancements. Major companies operating in this market are developing cutting-edge technologies to maintain their position. For example, in June 2023, UCB, a pharmaceutical company based in Belgium, received approval from the U.S. Food and Drug Administration (FDA) for RYSTIGGO (rozanolixizumab-noli). This approval, expedited under Priority Review, is for the treatment of generalized myasthenia gravis (gMG) in adults who test positive for anti-acetylcholine receptor (AchR) or anti-muscle-specific tyrosine kinase (MuSK) antibodies. RYSTIGGO holds the distinction of being the sole FDA-approved therapy for gMG positive for both anti-AchR and anti-MuSK antibodies, encompassing the two most common subtypes of this condition diagnosis of autoimmune illnesses, which has the potential to enhance provider efficiency, increase treatment efficacy, and improve patient care.
Which Key Market Players Are Investing In Expansion And Innovation Of Autoimmune Treatment Market?
Major companies operating in the autoimmune treatment market are Abbott Laboratories, Amgen Inc., Johnson & Johnson Services Inc., Eli Lilly and Company, Pfizer Inc., Hoffmann-La Roche AG, AstraZeneca PLC, Bristol-Myers Squibb Company, Autoimmune Inc., Siemens Healthcare Private Limited, Thermo Fisher Scientific Inc., Biogen Idec Inc., Bayer Schering Pharma AG, GSK PLC, Genentech Inc., AbbVie Inc., Celgene Corporation, Gilead Sciences Inc., Merck & Co. Inc., Novartis International AG, Sanofi SA, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., UCB SA, Alexion Pharmaceuticals Inc., Amarin Corporation PLC, AnaptysBio Inc., Apellis Pharmaceuticals Inc., Arena Pharmaceuticals Inc., Aurinia Pharmaceuticals Inc., BioCryst Pharmaceuticals Inc., Biohaven Pharmaceutical Holding Company Ltd., BioMarin Pharmaceutical Inc., bluebird bio Inc., Cabaletta Bio Inc., Catabasis Pharmaceuticals Inc., ChemoCentryx Inc., Coherus BioSciences Inc., Corbus Pharmaceuticals Holdings Inc., CSL Limited, Cumberland Pharmaceuticals Inc., CytoDyn Inc.
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/autoimmune-treatment-global-market-report
Which Region Is Expected To Witness The Fastest Growth In The Autoimmune Treatment Market?
North America was the largest region in the autoimmune treatment market in 2024. The regions covered in the autoimmune treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Autoimmune Treatment Market Report:
https://www.thebusinessresearchcompany.com/customise?id=7863&type=smp
Browse Through More Reports Similar to the Global Autoimmune Treatment Market 2025, By The Business Research Company
Autoimmune Disease Diagnosis Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/autoimmune-disease-diagnosis-global-market-report
Benign Prostatic Hyperplasia Bph Treatment Devices And Equipment Global Market Report 2025
Fertility Treatments Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/fertility-treatments-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model